Nicholas Ward's Dividend Growth Portfolio: July 2020 Update

Published Mon, 10 Aug 2020 10:21:18 -0400 on Seeking Alpha

Seeking AlphaDividend StrategyNicholas Ward's Dividend Growth Portfolio: July 2020 UpdateAug. 10, 2020 10:21 AM ET|| Includes: AAPL, ABBV, AMGN, AMZN, AVB, AVGO, BAM, BEP, BEPC, BIPC, BLK, BMY, CARR, CMCSA, CSCO, D, DEO, DIS, DLR, EBBNF, ENB, ENBBF, ESS, FB, FRT, GOOG, GOOGL, HD, HON, IBM, INTC, ITW, IVZ, JNJ, KO, LOW, MA, MDT, MKC, MKC.V, MMM, MO, MSFT, NKE, NNN, NVDA, NVO, O, OTIS, PEP, PFE, QCOM, RTX, SBUX, SPY, STOR, STZ, STZ.B, T, TXN, V, VIAC, VIACA, VZ, WPCby: Nicholas WardNicholas Ward The Dividend KingsDividend ideas from a top team of analysts to help you sleep well at night.SummaryDisney's dividend suspension came back to bite me this month.
However, year-to-date, my passive income is still up 10.5% compared to the first 7 months of 2019.
Year-to-date, my total returns are 4.82%.
Another month, another step towards financial freedom.
July was a wonderful month for the broader markets. The S&P 500 was up roughly 5.5% as the COVID-19 recovery rally continues.
My personal portfolio saw gains of roughly 4.6% during the month, showing a bit of short-term underperformance.
However, I never get upset about such short-term price movement. Thus far, year-to-date, my portfolio's value has increased by 4.82%, which is still outpacing the YTD returns of 2.30% returns that the SPDR S&P 500 ETF (SPY) has generated. I do hope to beat the market every year on an annual basis, so here's to hoping that I can maintain this lead throughout the remainder of the year.
Core Dividend Growth
47.12% Company name Ticker Cost basis Portfolio Weighting Apple AAPL $103.78 15.87% Microsoft MSFT $53.17 4.65% Cisco CSCO $32.95 3.33% Bristol Myers Squibb BMY $48.75 2.73% Johnson & Johnson JNJ $113.07 2.46% BlackRock BLK $413.84 2.44% Qualcomm QCOM $60.29 2.40% PepsiCo PEP $92.39 1.52% Amgen AMGN $130.50 1.37% Coca-Cola KO $39.78 1.17% Honeywell HON $123.87 1.17% Illinois Tool Works ITW $130.90 1.04% Texas Instruments TXN $95.19 1.03% Novo Nordisk... Read more